SAFElife™ T-Dip 1-Panel Urine Test Card – Benzodiazepines (BZO)
$21.00
In stock
SKU
WDBZ-114
Product Highlights
•CLIA-waived
•Single-analyte benzodiazepines (BZO) screen at 300 ng/mL
•Point-of-care dip-and-read, no instrument
•Sold by the box (25 tests per box)
Buy 2 for $19.75 each and save 6%
Buy 4 for $18.75 each and save 11%
Buy 10 for $17.75 each and save 15%
Buy 20 for $16.75 each and save 20%
Quick Overview
The SAFElife™ T-Dip Benzodiazepines (BZO) urine test card is a single-panel, point-of-care dip card that screens human urine for benzodiazepines at a 300 ng/mL cutoff. Sold by the box: 1 box = 25 tests, order any number of boxes.
SAFElife™ T-Dip 1-Panel Urine Test Card – Benzodiazepines (BZO)
The SAFElife™ T-Dip Benzodiazepines (BZO) urine test card is a single-panel, point-of-care dip card that screens human urine for benzodiazepines at a 300 ng/mL cutoff. Sold by the box: 1 box = 25 tests, order any number of boxes.
Details
A benzodiazepines (BZO) result at 300 ng/mL is the qualitative screen. This single-analyte T-Dip card gives one clean answer per specimen, read at the point of care, with no instrument.
Test at a glance
Analyte
Benzodiazepines (BZO)
Cutoff
300 ng/mL
Specimen
Urine
Format
Single-panel dip card
Regulatory status
CLIA-waived
How to run it
1
Collect
Collect a fresh urine specimen in a clean cup.
2
Dip
Dip to the mark line. Do not immerse past the mark.
3
Read
Read per the package insert. Two lines = negative; C only = preliminary positive; no C = invalid.
A preliminary positive should be confirmed by a more specific method such as GC/MS or LC/MS.
How it is sold
By the box. One box is 25 tests, the minimum is one box, and there is no ceiling — a program needing 3,000 tests orders 120 boxes with no change of item. Twenty boxes is a sealed case.
Regulatory
CLIA-waived.
Pharmacies and compounding pharmaciesHospital and health-system pharmacyLong-term care and skilled nursingHome health and hospiceUrgent care and physician officesCorrectional health
This card is one of SAFElife's single-analyte T-Dip line: the same rigid dip-card format as the multi-panel T-Dip cards, but built around one substance instead of several. A program that already stocks multi-panel T-Dip cards can add this single-analyte card alongside them using the same collect, dip, and read steps — no new training, no new equipment. Ordering by single analyte instead of a fixed panel lets a program match a testing policy precisely: add benzodiazepine screening to an existing panel, run it as a stand-alone confirmatory step, or stock it for a population where only this one substance needs to be tracked. Each box holds 25 individual test cards, and volume pricing steps down at higher box counts, so an order that starts small and later scales up moves to a lower per-test price automatically.
Compliance & Safety
This single-panel benzodiazepines (BZO) card is CLIA-waived at a 300 ng/mL cutoff. It provides a preliminary qualitative result; a more specific alternate method such as GC/MS or LC/MS is required to obtain a confirmed result.
Manufactured by Wondfo USA in ISO-certified facilities.
